question archive One-third of adult women in the United States may experience female hypoactive sexual desire disorder (HSDD)
Subject:NursingPrice: Bought3
One-third of adult women in the United States may experience female hypoactive sexual desire disorder (HSDD). HSDD is a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty.
Several female reproductive life experiences may uniquely affect sexual desire. These events include menstrual cycles, hormonal contraceptives, postpartum states and lactation, oophorectomy and hysterectomy, and perimenopausal and postmenopausal states (Warnock, 2002). Notably, HSDD shares some similarity with depression, as its etiology can be explained using a biopsychosocial model that includes biological, psychological, and sociocultural factors, as well as interpersonal influences (Kingsberg, 2020). Thus, female HSDD can greatly impact the quality of life.
HSDD is well established as a valid and treatable clinical diagnosis. Even for those inexperienced in treating sexual problems, there are simple and validated screening tools such as the Decreased Sexual Desire Screener that can help identify HSDD and a need for further evaluation and treatment. Despite the current consensus in the literature that HSDD can manifest at any age in a woman’s life, it is documented that during menopause, up to 40% of women experience reduced sexual libido (AlAwlagi, Amor & Hammadeh, 2017).
DSM 5 Criteria
Specify whether:
Specify whether:
Specify current severity:
Despite the stigma, this issue has gained attention in the medical field. In addition, several pharmacologic agents have been designed to target HSDD and are in various stages of clinical trials. However, the field continues to face some hurdles including a lack of information, confusion over medications and management, and the discomfort associated with addressing the subject of sexuality (AlAwlaqi, Amor & Hammadeh, 2017).